These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33039564)

  • 1. Design, synthesis, antimycobacterial activity and molecular docking studies of novel 3- (N-substituted glycinamido) benzoic acid analogues as anti tubercular agents.
    Veeravarapu H; Tirumalasetty M; Kurati S; Wunnava U; Krishna Kumar Muthyala M
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127603. PubMed ID: 33039564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents.
    Veeravarapu H; Malkhed V; Mustyala KK; Vadija R; Malikanti R; Vuruputuri U; Muthyala MKK
    Mol Divers; 2021 Feb; 25(1):351-366. PubMed ID: 32533514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural comparison of Mtb-DHFR and h-DHFR for design, synthesis and evaluation of selective non-pteridine analogues as antitubercular agents.
    Sharma K; Tanwar O; Sharma S; Ali S; Alam MM; Zaman MS; Akhter M
    Bioorg Chem; 2018 Oct; 80():319-333. PubMed ID: 29986181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents.
    Jian Y; Hulpia F; Risseeuw MDP; Forbes HE; Munier-Lehmann H; Caljon G; Boshoff HIM; Van Calenbergh S
    Eur J Med Chem; 2020 Sep; 201():112450. PubMed ID: 32623208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors.
    Kronenberger T; Ferreira GM; de Souza ADF; da Silva Santos S; Poso A; Ribeiro JA; Tavares MT; Pavan FR; Trossini GHG; Dias MVB; Parise-Filho R
    Bioorg Med Chem; 2020 Aug; 28(15):115600. PubMed ID: 32631571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Furan Coupled Quinoline Diamide Hybrid Scaffolds as Potent Antitubercular Agents: Design, Synthesis and Molecular Modelling.
    Rajpurohit A; Satyanarayan ND; Pathak L; Ayyanar S; Rishinaradamangalam CR; Shoorapani P
    Med Chem; 2020; 16(4):507-516. PubMed ID: 31483232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
    Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
    Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
    Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Aminopyrazole Tagged Hydrazones as Anti-Tubercular Agents: Synthesis and Molecular Docking Studies.
    Padmini T; Bhikshapathi D; Suresh K; Kulkarni R; Kamal BR
    Med Chem; 2021; 17(4):344-351. PubMed ID: 32407282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
    Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives.
    Naidu KM; Srinivasarao S; Agnieszka N; Ewa AK; Kumar MM; Chandra Sekhar KV
    Bioorg Med Chem Lett; 2016 May; 26(9):2245-50. PubMed ID: 27020525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent.
    Ambhore AN; Kamble SS; Kadam SN; Kamble RD; Hebade MJ; Hese SV; Gaikwad MV; Meshram RJ; Gacche RN; Dawane BS
    Comput Biol Chem; 2019 Jun; 80():54-65. PubMed ID: 30901601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and molecular docking of substituted 3-hydrazinyl-3-oxo-propanamides as anti-tubercular agents.
    Naqvi A; Malasoni R; Srivastava A; Pandey RR; Dwivedi AK
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5181-4. PubMed ID: 25442308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
    Dadlani VG; Chhabhaiya H; Somani RR; Tripathi PK
    Chem Biol Drug Des; 2022 Aug; 100(2):230-244. PubMed ID: 35434882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
    Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
    Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies.
    Pisal MM; Nawale LU; Patil MD; Bhansali SG; Gajbhiye JM; Sarkar D; Chavan SP; Borate HB
    Eur J Med Chem; 2017 Feb; 127():459-469. PubMed ID: 28103537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
    Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
    Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
    Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.